Amgen Inc. buy Royal Bank of Canada
Start price
15.01.26
/
50%
€284.25
Target price
15.01.27
€287.83
Performance (%)
14.94%
Price
09:02
€326.45
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada currently has a performance of 14.94%. A total of €2.52 was paid as dividends for this prediction. This prediction currently runs until 15.01.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | -1.652% | -1.652% |
| iShares Core DAX® | -3,52 % | -4,99 % |
| iShares Nasdaq 100 | 0,26 % | 1,10 % |
| iShares Nikkei 225® | -4,95 % | -3,35 % |
| iShares S&P 500 | -0,82 % | -0,04 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Amgen Inc. diskutieren
Amgen (NASDAQ:AMGN) had its price target raised by analysts at Royal Bank Of Canada from $330.00 to $335.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat